Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacokinetics in renal disease

G Levy

    The American Journal of Medicine
    |April 1, 1977
    PubMed
    Summary

    Renal disease alters drug elimination kinetics, affecting drug clearance and steady-state plasma concentrations. Dosage adjustments are crucial, especially during hemodialysis, to manage drug accumulation and metabolite risks.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection.

    The Journal of experimental medicine·1992
    Same author

    From front line to home front: a study of secondary traumatization.

    Family process·1992
    Same author

    Publication bias: its implications for clinical pharmacology.

    Clinical pharmacology and therapeutics·1992
    Same author

    Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development.

    Journal of pharmaceutical sciences·1992
    Same author

    Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development.

    Pharmaceutical research·1992
    Same author

    Comparison of functional activity in host and graft mesenteric lymphoid tissue of rats receiving syngeneic heterotopic small bowel allografts with portal or systemic drainage.

    Transplantation proceedings·1992

    Area of Science:

    • Pharmacokinetics
    • Nephrology
    • Drug Metabolism

    Background:

    • Renal disease significantly impacts drug elimination pathways.
    • Drug clearance, a measure of elimination rate, is critical for determining drug efficacy and toxicity.
    • Understanding these effects is vital for safe and effective drug therapy in patients with kidney impairment.

    Purpose of the Study:

    • To elucidate the pharmacokinetic alterations in drug elimination due to renal disease.
    • To explain the relationship between renal function, drug clearance, and plasma concentrations.
    • To provide guidance on drug dosing adjustments in renal impairment and during hemodialysis.

    Main Methods:

    • Analysis of drug clearance routes (renal, hepatic, etc.) and their contribution to total body clearance.
    • Correlation of renal clearance reduction with creatinine clearance in renal disease.
    • Assessment of changes in plasma protein binding and its effect on metabolic clearance.

    Main Results:

    • Renal disease proportionally reduces renal drug clearance, often mirroring creatinine clearance reduction.
    • Decreased plasma protein binding in renal disease can increase metabolic clearance of certain drugs.
    • Hemodialysis can significantly contribute to drug clearance, necessitating dosage adjustments.

    Conclusions:

    • Drug dosing regimens require careful modification in patients with renal disease.
    • Dosage compensation during hemodialysis is essential to prevent sub- or supra-therapeutic drug levels.
    • Accumulation of active drug metabolites in renal failure poses a significant clinical concern.

    Related Experiment Videos